relationship between the risk of colon cancer development and In experiment 4, using the multicarcinogenic protcol we intake of non-steroidal anti-inflammatory agents, including could analyze our data with respect to not only one separate aspirin. One of the mechanisms by which non-steroidal antiorgan, but at the organism level. Sixty-eight male, 6-weekinflammatory agents inhibit colon carcinogenesis is related to old rats were treated with DMH, N-methylnitrosourea, their inhibition of prostaglandin production by induction of 2,2Ј-dihydroxy-di-n-propylnitrosamine, diethylnitrosamine cyclooxygenase isozymes (COX-1 and COX-2). Overexpresand N-butyl-N-(4-hydroxybutyl)nitrosamine in weeks 1-4 sion of COX-2 has been observed in colon tumors (12). and were then given 24R,25(OH) 2 D 3 in the diet (5, 1 or Quantification of formation and growth of aberrant crypt 0 p.p.m.) throughout weeks 5-30. Examination of the foci (ACF) in the rodent colon has been used as a short-term development of tumors and preneoplastic lesions in various bioassay to evaluate the role of nutritional components at a organs revealed that 24R,25(OH) 2 D 3 inhibited colonic very early stage of colon carcinogenesis (13). Several observatumor development significantly but exerted no effects on tions have confirmed the putative association between ACF tumor induction in other organs. In conclusion, these and colon cancer in both rodents (14) and humans (15). results strongly indicate that 24R,25(OH) 2 D 3 inhibits colon Moreover, many of the genetic alterations characteristic of carcinogenesis specifically, without any enhancement of colon cancer are observed in ACF (16, 17) . carcinogenesis in other organs, when administered in the It is important to detect chemicals which show potential to post-initiation phase.
.). Animals
during the post-initiation phase. We also reported an effect of were injected with 5-bromo-2Ј-deoxyuridine (BrdU) i.p. 1 24R,25(OH) 2 D 3 on rat colon carcinogenesis when administered h before death to examine DNA synthesis in the colon before, during or after carcinogen administration (11) . mucosa. BrdU labeling indices were decreased dose-dependEpidemiological and laboratory studies indicate an inverse ently in colonic crypts of rats treated with 24R,25(OH) 2 D 3 .
relationship between the risk of colon cancer development and In experiment 4, using the multicarcinogenic protcol we intake of non-steroidal anti-inflammatory agents, including could analyze our data with respect to not only one separate aspirin. One of the mechanisms by which non-steroidal antiorgan, but at the organism level. Sixty-eight male, 6-weekinflammatory agents inhibit colon carcinogenesis is related to old rats were treated with DMH, N-methylnitrosourea, their inhibition of prostaglandin production by induction of 2,2Ј-dihydroxy-di-n-propylnitrosamine, diethylnitrosamine cyclooxygenase isozymes (COX-1 and COX-2). Overexpresand N-butyl-N-(4-hydroxybutyl)nitrosamine in weeks 1-4 sion of COX-2 has been observed in colon tumors (12) . and were then given 24R,25(OH) 2 D 3 in the diet (5, 1 or Quantification of formation and growth of aberrant crypt 0 p.p.m.) throughout weeks 5-30. Examination of the foci (ACF) in the rodent colon has been used as a short-term development of tumors and preneoplastic lesions in various bioassay to evaluate the role of nutritional components at a organs revealed that 24R,25(OH) 2 D 3 inhibited colonic very early stage of colon carcinogenesis (13) . Several observatumor development significantly but exerted no effects on tions have confirmed the putative association between ACF tumor induction in other organs. In conclusion, these and colon cancer in both rodents (14) and humans (15 experimental period (18) (19) (20) and is based on the strong carcinogenesis. In addition, the modifying effects of Experiment 3. Fifteen, 9-week-old rats were randomly divided into three 24R,25(OH) 2 D 3 on carcinogenesis in other organs were evalugroups (5 rats/group). Animals in groups 1 and 2 were given 24R,25(OH) 2 D 3 ated using the multiorgan carcinogenensis bioassay.
in the diet (10 and 5 p.p.m. in powdered basal diet, respectively) for 4 weeks. The animals in group 3 were given the basal powdered diet without 24R,25(OH) 2 D 3 . The animals were treated with 5-bromo-2Ј-deoxyuridine
Materials and methods
(BrdU) (Sigma Japan) at a dose of 100 mg/kg body wt i.p. 1 h before death. Animals Animals were killed under ether anesthesia at the end of week 4 for Male F344 rats were obtained at 5 weeks of age (Charles River Japan Inc., examination of the BrdU labeling index and COX-2 index in the colon. Hino, Japan) and housed in plastic cages with wood chips under controlled Experiment 4. The experimental design is shown in Figure 1 . Sixty-eight, conditions of a 12 h light/12 h dark cycle, 44 Ϯ 5% humidity and 22 Ϯ 2°C 6-week-old rats were randomly divided into five groups. Animals in groups temperature. Diet and water were available ad libitum and body weights, food 1-3 (16 rats each in groups 1 and 2; 20 rats in group 3) were given a combined and water intake were measured weekly during the experiments. drinking water for 2 weeks (during weeks 1 and 2) and 0.1% DHPN in the (Tokyo, Japan).
drinking water for 2 weeks (during weeks 3 and 4). After the DMBDD Treatment treatment, the rats were maintained without any treatment for 1 week. The rats in groups 1 and 2 then received 24R,25(OH) 2 D 3 -containing (5 p.p.m. in Experiment 1. Fifty, 6-week-old rats were randomly divided into five groups (10 rats/group). Animals were given s.c. injections of DMH dissolved in group 1; 1 p.p.m. in group 2) powdered basal diet and the rats in group 3 received basal diet only, as a control. In addition, eight rats in group 4 received normal saline solution (20 mg/kg body wt) once a week for 4 weeks. After DMH treatment, the animals in groups 1-4 were given 24R,25(OH) 2 D 3 -5 p.p.m. 24R,25(OH) 2 D 3 -containing diet from week 5 to 30 without the prior DMBDD treatment and eight rats in group 5 received basal diet during the containing diet (10, 5, 2.5 or 1.25 p.p.m. in powdered basal diet) during weeks 5-12. The animals in group 5 were given the powdered basal diet experiment without the DMBDD treatment. The total period of experimental observation was 30 weeks. All surviving animals were exsanguinated under without 24R,25(OH) 2 D 3 . The total period of experimental observation was 12 weeks, after which the animals were killed under ether anesthesia and the anesthesia and completely autopsied at the beginning of week 31. The blood was used for serum chemical determinations. The livers and kidneys were colon was excised. Afterwards, the colons were distended in 10% phosphatebuffered formalin solution for 1 min, then opened along the mesenteric surface removed and weighed and all major organs were excised and fixed in 10% phosphate-buffered formalin solution. The colons were stained in 0.2% and fixed flat between two sheets of filter paper for ACF examination. The No. of rats BrdU labeling index (%) Experiment 4. Anti-GST-P antibodies were raised as previously described (23) . The avidin-biotin-peroxidase complex (ABC) method was performed 10 5 7.02 Ϯ 1.10 a as previously described. 5 5 11.67 Ϯ 0.75 Serum and urine examination 0 5 15.84 Ϯ 1.72 Experiments 1 and 4. Urine samples were collected from the animals in the morning on the day of death. Blood samples were collected at autopsy and a P Ͻ 0.05 (versus control).
centrifuged at 3000 r.p.m. for 15 min. Urine and serum samples were analyzed for calcium and phosphate levels (urine, Hitachi-710 electrolyte analyzer; methylene blue for 1 min and examined for ACF by light microscopy. All serum, Hitachi-7150; Hitachi, Tokyo, Japan). the organs were embedded in paraffin and used for sectioning with routine ODC and SAT activity hematoxylin and eosin staining for histopathological examination. Three slices from the liver were used for immunohistochemical staining of glutathione SExperiment 5. ODC and SAT activities were measured as previously described by Otani et al. (24) and Matsui et al. (25) . Frozen rat colonic epithelium transferase placental form (GST-P)-positive foci. Experiment 5. Twenty, 6-week-old rats were divided into two groups. Animals samples were suspended in 0.5 ml of 50 mM Tris containing 0.25 M sucrose and disrupted with a homogenizer for 30 s. The homogenized suspensions in group 1 received 5 p.p.m. 24R,25(OH) 2 D 3 in the diet for 4 weeks. Animals in group 2 received basal diet only during the experiment. The colons were centrifuged at 100 000 g for 30 min and the supernatant was assayed for ODC and SAT activity by measurement of the amount of radioactive were removed, flushed with phosphate-buffered saline, cut open along the longitudinal median axis and then divided in half. The attached colonic putrescine produced from [5- 14 C]ornithine and the amount of moiety transferred from [1-14 C]acetylcoenzyme A to spermidine, respectively. mucosa was scraped off with glass slides. The colon mucosa specimens were used for ornithine decarboxylase (ODC) and spermidine/spermine N 1 -Statistical analysis acetyltransferase (SAT) assays.
Data were analyzed using Student's t-test (Stat View SEϩ Graphics; Abacus ACF count assay Concepts Inc., USA). Experiments 1, 2 and 4. After fixation colons were stained in 0.2% methylene blue for 1 min and examined for ACF by light microscopy. The number of
Results
ACFs in each segment, as well as the number of aberrant crypts in each focus, were counted.
Experiment 1 Immunohistochemical staining
All rats survived until the final termination. Final body and in kidneys of rats treated with 24R,25(OH) 2 D 3 . Urine calcium colonic epithelium in 24R,25(OH) 2 D 3 -treated groups were levels were dose-dependently increased in rats treated with lower than in the control group in a dose-dependent manner, 24R,25(OH) 2 D 3 (Table I) . Serum calcium levels were also in particular, group 1 was significantly decreased compared dose-dependently increased in treated animals but the increases with the controls, group 3. COX-2 immunoreactivity was in serum calcium levels were slight. Serum phosphorus levels localized in the perinuclear cytoplasm of colonic crypt cells, were comparable among the groups.
as well as in a few mesenchymal cells detected in between The number of ACF in the colon dose-dependently decreased the crypts. COX-2 indices in rat colon mucosa were not in rats treated with 24R,25(OH) 2 D 3 , even at the lowest dose significantly different in each group (0.8% in group 1, 0.76% (1.25 p.p.m.) administered (Figure 2) . Although ACF larger in group 2 and 1.21% in group 3). than four crypts per foci were correlated with the treatment Experiment 4 doses, statistical significance was not observed. In addition, Two rats in each of groups 1-3 died during the observation the size and number of ACF were also significantly correlated period. One rat in group 2 died at week 25 and had a colon with the treatment doses.
adenocarcinoma and one rat in group 3 died at week 28 and Experiment 2 had a thymoma. The tumor data for animals dying during the All rats survived until the final termination. Final body and observation period were not available. Final average body relative liver and kidney weights did not significantly differ weights were not significantly different between groups 1-3, among groups. Water consumption was increased in groups but the final average body weights of animals in groups 1-3 treated with 24R,25(OH) 2 D 3 . No deposition of calcium was were significantly lower than in groups 4 and 5. The left observed in kidneys of rats treated with 24R,25(OH) 2 D 3 . The kidney weight in group 1 was significantly different from number of ACF did not differ significantly among the groups group 3 because there were two rats with large tumors in the (Figure 3) . The number of ACF appears to be higher in the left kidney in group 1. distal colon in all of the carcinogen-treated groups.
The colon tumor (adenoma and/or adenocarcinoma) incidExperiment 3 ence and multiplicity were significantly lower in the 5 p.p.m. 24R,25(OH) 2 D 3 group (group 1) than in the control group All rats survived until the final termination. Final average (Figure 4) . However, an effect of 24R,25(OH) 2 D 3 on formation body weights of the animals did not differ significantly among of GST-P-positive foci in the liver was not observed (Figure  groups 1-3 . adenoma. Since the initiating action of the DMBDD treatment pmol/h/mg protein), but the level of SAT activity in the colonic in the present study appears to be weak, an inhibitory effect epithelium of the 24R,25(OH) 2 D 3 group was significantly on glandular stomach carcinogenesis might be masked. lower (2.17 Ϯ 0.66 fmol/mg protein) than in the control group A chemical may act as a tumor inhibitor in one organ and (3.5 1 Ϯ 1.01 fmol/mg protein).
as a tumor promoter in other organs (18, 35, 36) . It is therefore important to examine the modification potential not only in a Discussion single organ, but rather in the whole body. Recently, multiThe present study has demonstrated that dietary organ carcinogenesis models have been developed for the 24R,25(OH) 2 D 3 has a chemopreventive action against colon detection of carcinogens, promoters or inhibitors of the whole carcinogenesis in rats induced by DMH in the post-initiation body in individual rats subjected to a wide-spectrum initiation phase but not during the initiation phase. Administration of protocol (18) (19) (20) (37) (38) (39) (40) . The present multi-organ carcinogen-24R,25(OH) 2 D 3 during the post-initiation phase reduced the esis model has already proved useful. The present study clearly number of DMH-induced ACF in colonic epithelium in a doseindicates that 24R,25(OH) 2 D 3 does not promote carcinogenesis dependent manner and 24R,25(OH) 2 D 3 significantly inhibited in any of the organs examined. The lack of any possible the number and incidence of colon tumors induced by the interaction with carcinogen initiation allows assessment in all DMBDD protocol.
organs. The present study demonstrates that 24R,25(OH) 2 D 3 The inhibitory mechanism of 24R,25(OH) 2 D 3 is not likely inhibits colon carcinogenesis when administered in the postthrough modification of the metabolic pathway of DMH, since initiation phase without any enhancement of carcinogenesis in it did not influence colon carcinogenesis on simultaneous other organs. treatment with DMH. However, it cannot be excluded that the inhibitory effect of 24R,25(OH) 2 D 3 is mediated by calcium. Several investigators have reported that calcium and vitamin
